Megan R. Carey is a Group Leader in the Neuroscience Program at the Champalimaud Center for the Unknown in Lisbon, Portugal. She received her PhD in 2005 from the University of California, San Francisco, where her thesis was awarded UCSF’s Krevans Distinguished Dissertation Award. After a Helen Hay Whitney Postdoctoral Fellowship at Harvard Medical School, Dr. Carey started her independent laboratory at the Champalimaud. Her lab combines quantitative behavioral analysis, genetics, and physiology to understand how the brain controls learned and coordinated movements.
Dr. Carey was an International Early Career Scientist of the Howard Hughes Medical Institute from 2012-2017 and received a Starting Grant from the European Research Council in 2015. She is a Scholar, and the current Chair, of the FENS-Kavli Network of Excellence. She has co-chaired a number of international scientific conferences, including the Gordon Research Conference on the Cerebellum (Maine, USA), COSYNE (Computational and Systems Neuroscience, Utah, USA), the Champalimaud Neuroscience Symposium, and the Forum of the Federation of European Neuroscience Societies (FENS, Copenhagen, Denmark, 2016; Berlin, Germany, 2018).
Dr. Carey has served as a policy advisor to the European Commission as a member of the RISE (Research, Innovation, and Science Experts) high-level group since 2015.